Korean drug developer Mecox CureMed gains speed in U.S. business expansion
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
Mecox Medi is responsible for clinical development of drugs in the parent company’s pipeline overseas, listing shares on the Nasdaq and attraction of overseas investors.
Mecox CureMed plans to conduct R&D for major candidate drugs, including Covid-19 cure M002-A, arthritis drug Bozanics and oncology drug Mecbentu, through the U.S. subsidiary.
Mecox CureMed said it will seek business expansion in the U.S. based on its patented technology, and it is currently working together with Black Canyon Capital, a U.S. private equity financing firm, to implement necessary tasks such as funding from external investors and listing on the U.S. OTC market with a final goal of going public on the Nasdaq. The company’s business expansion idea was first proposed by Black Canyon Capital in October last year, it said.
The U.S. consultancy has a track record of listing portfolio companies on the U.S. stock market.
[ⓒ Maeil Business Newspaper & mk.co.kr, All rights reserved]
Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지
- Naver, CU to jointly develop O2O commerce platform for convenience stores - Pulse by Maeil Business News Korea
- SK Bioscience wins gov’t order to distribute Covid-19 vaccines in S. Korea - Pulse by Maeil Business News Korea
- Korea’s first EV-dedicated charging station opens in eastern Seoul - Pulse by Maeil Business News Korea
- Cash-deprived SsangYong Motor employees unlikely to get full salary in Jan-Feb - Pulse by Maeil Business News Korea
- Foreign investors drive Korea’s latest stock rally - Pulse by Maeil Business News Korea
- 강경준, 상간남 피소…사랑꾼 이미지 타격 [MK픽] - 스타투데이
- 제2회 대한민국 NFT디지털아트대전 결과 발표 [ISSUE]
- “‘음악’으로 맺어진 ♥”…윤보미·라도, 8년째 열애 ‘인정’(종합)[MK★이슈] - MK스포츠
- 이찬원, 이태원 참사에 "노래 못해요" 했다가 봉변 당했다 - 스타투데이
- 양희은·양희경 자매, 오늘(4일) 모친상 - 스타투데이